v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 564,707 $ 4,258 $ 740,949 $ 373,948
Cost of sales 2,815,242 1,423,904 6,074,577 3,751,674
Gross loss (2,250,535) (1,419,646) (5,333,628) (3,377,726)
Operating expenses        
Selling, general and administrative 5,950,058 2,551,406 15,464,926 6,638,350
Research and development 1,614,485 1,640,454 5,133,325 4,219,456
Total operating expenses 7,564,543 4,191,860 20,598,251 10,857,806
Other income 0 0 864,900 0
Loss from operations (9,815,078) (5,611,506) (25,066,979) (14,235,532)
Interest expense, net 74,315,644 5,882,081 185,638,961 23,582,427
Loss before provision for income taxes (84,130,722) (11,493,587) (210,705,940) (37,817,959)
Provision for income taxes 0 0 0 0
Net loss $ (84,130,722) $ (11,493,587) $ (210,705,940) $ (37,817,959)
Net loss attributable to common stockholders per share - basic and diluted (in dollars per share) $ (0.78) $ (0.17) $ (2.52) $ (0.60)
Weighted average number of common shares outstanding - basic and diluted (in shares) 107,406,000 66,176,921 83,611,526 63,566,295

Source